Search results
Why Shares of Invitae Rose 11% on Tuesday
Motley Fool· 2 years agoShares of medical genetics testing company Invitae (NYSE: NVTA) rose 11% on Tuesday. Invitate didn't have any announcements on Tuesday, though it is...
Invitae sells reproductive health assets amid liquidity concerns
MedTech Dive via Yahoo Finance· 4 months agoDive Brief: Medical genetics firm Invitae sold its reproductive health assets to Natera for up to...
Invitae aims to regain NYSE compliance after average share price falls below $1
Investing.com via Yahoo Finance· 8 months agoSan Francisco-based medical genetics company, Invitae (NYSE:NVTA), received a notice from the New York Stock Exchange (NYSE) on Tuesday, indicating that the firm is not in compliance with Section ...
SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy
Benzinga via Yahoo Finance· 3 months agoInvitae Corporation (NYSE:NVTA), backed by SoftBank Group (OTC:SFTBY) (OTC:SFTBF), is reportedly on...
Why Invitae Stock Is Crushing It Today
Motley Fool· 2 years agoInvitae (NYSE: NVTA) stock was absolutely crushing it on Wednesday, with its shares skyrocketing 19.4% higher as of 11:11 a.m. ET. The huge gain came...
Invitae Stock Soars 277% in a Day: Time to Buy?
Motley Fool· 2 years agoFor medical genetics specialist Invitae's (NYSE: NVTA) downtrodden investors, there was a lot riding on the company's second-quarter earnings release. An 85% share decline year to date can impart ...
PacBio's (PACB) New Tie-Up to Boost Rare Disease Research
Zacks via Yahoo Finance· 11 months agoPacific Biosciences of California, Inc. PACB, popularly known as PacBio, announced a clinical...
The human Y chromosome has finally been fully sequenced, 20 years after the 1st draft
Live Science via Yahoo News· 9 months agoIllustration of human Y chromosome with DNA strands shown inside The Y chromosome, associated with...
Labcorp to acquire Invitae’s assets for $239M
MedTech Dive via Yahoo Finance· 4 weeks agoWilliam Blair analyst Andrew Brackmann said Labcorp is being aggressive in its M&A strategy, after announcing last month it would buy several of...
Invitae Corp (NVTA) Reports Mixed Third Quarter 2023 Financial Results Amid Operational Adjustments
GuruFocus.com via Yahoo Finance· 6 months agoInvitae Corp (NYSE:NVTA) reported a 9% year-over-year revenue decrease to $121.2 million in Q3 2023,...
